'The smoking toolkit study': a national study of smoking and smoking cessation in England by Fidler, JA et al.
RESEARCH ARTICLE Open Access
’The smoking toolkit study’: a national study of
smoking and smoking cessation in England
Jennifer A Fidler1*, Lion Shahab1, Oliver West2, Martin J Jarvis1, Andy McEwen1, John A Stapleton1, Eleni Vangeli1
and Robert West1
Abstract
Background: Up-to-date data tracking of national smoking patterns and cessation-related behaviour is required to
evaluate and inform tobacco control strategies. The Smoking Toolkit Study (STS) was designed for this role. This
paper describes the methodology of the STS and examines as far as possible the representativeness of the
samples.
Methods: The STS consists of monthly, cross sectional household interviews of adults aged 16 and over in England
with smokers and recent ex-smokers in each monthly wave followed up by postal questionnaires three and six
months later. Between November 2006 and December 2010 the baseline survey was completed by 90,568
participants. STS demographic, prevalence and cigarette consumption estimates are compared with those from the
Health Survey for England (HSE) and the General Lifestyle Survey (GLF) for 2007-2009.
Results: Smoking prevalence estimates of all the surveys were similar from 2008 onwards (e.g 2008 STS = 22.0%,
95% C.I. = 21.4% to 22.6%, HSE = 21.7%, 95% C.I. = 20.9% to 22.6%, GLF = 20.8%, 95% C.I. = 19.7% to 21.9%),
although there was heterogeneity in 2007 (chi-square = 50.30, p < 0.001). Some differences were observed across
surveys within sociodemographic sub-groups, although largely in 2007. Cigarette consumption was virtually
identical in all surveys and years.
Conclusion: There is reason to believe that the STS findings (see http://www.smokinginengland.info) are
generalisable to the adult population of England.
Background
The UK is one of the leading countries with regard to
policies aimed at reducing mortality and morbidity from
tobacco smoking [1]. Up-to-date and detailed surveil-
lance data are important for evaluating the effectiveness
of the UK’s tobacco control strategy, making recommen-
dations concerning different methods of encouraging
smoking cessation, and helping shape government and
health service policy. Findings from the UK can also be
used to inform policy internationally.
Several large-scale surveys collect data on tobacco
control parameters (Table 1). These surveys all provide
useful data, but have some limitations. First, most pro-
vide data which are out of date by up to two years at
time of publication [2]. This limits their ability to inform
tobacco control in a timely manner. Second, because the
two principal surveys in England, the General Lifestyle
Survey (GLF, formally the General Household Survey)
and the Health Survey for England (HSE) cover a wide
range of health and lifestyle topics, their data on smok-
ing patterns and cessation-related activities are limited.
By contrast, surveys such as the International Tobacco
Control (ITC) [3] and ATTEMPT [4] cohort studies col-
lect more smoking-related information. However, the
UK samples are relatively small. In addition, the
ATTEMPT study was limited to smokers interested in
quitting between certain ages and is not ongoing. The
ITC study follows a cohort of smokers annually but is
somewhat limited due to the exclusion of recent ex-
smokers from subsequent surveys and does not allow
fine grain tracking. Thus while these studies are crucial
to answering certain questions in the field of tobacco
control, it was judged that there was a need for an addi-
tional study to provide ongoing, up-to-date national
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statistics tracking key parameters relating to tobacco
smoking, especially prevalence, cessation, motivation to
stop, and harm reduction, and to provide contextual
information to help understand these data.
The Smoking Toolkit Study (STS) was designed to
achieve this goal. Detailed data are collected on a wide
range of smoking-related parameters at monthly inter-
vals. The study is ongoing and has thus far produced a
number of papers [5-17]. Up-to-date findings are also
published on a dedicated website: http://www.smokingi-
nengland.info. The purpose of this paper is twofold: 1)
to provide a description of the STS methodology in
greater detail than can be given in other papers, and 2)
to establish the generalisability of the samples by
comparing STS estimates with equivalent estimates
from the two principle established national surveys, the
GLF and the HSE, on demographics and two key
tobacco control parameters, smoking prevalence and
cigarette consumption.
Method
The STS involves monthly cross-sectional household
computer-assisted interviews, conducted by the British
Market Research Bureau as part of their monthly omni-
bus survey, of approximately 1,800 adults aged 16 and
over in England. Cigarette smokers and recent ex-
smokers (who have smoked in the past year) who agree
to be re-contacted are followed up three- and six-
months later by postal questionnaire. Baseline data were
first collected in November 2006, followed by three and
six month postal follow-ups in February and May 2007,
respectively. Due to funding constraints the three month
postal questionnaire was discontinued in January 2010.
The baseline surveys use a form of random location
sampling. England is split into 165,665 Output Areas,
each comprising approximately 300 households. These
Output Areas are stratified by ACORN characteristics
(an established geo-demographic analysis of the popula-
tion; http://www.caci.co.uk/acorn/ and geographic
region then randomly selected to be included in an
interviewer’s list. Interviewers travel to the selected
areas and perform computer assisted interviews with
one participant aged over 16 per household until quotas
based upon factors influencing the probability of being
at home (working status, age, and gender) are fulfilled.
Morning interviews are avoided to maximise participant
availability. Random location sampling is considered
superior to conventional quota sampling because the
choice of properties approached is reduced by the ran-
dom allocation of small output areas. However, inter-
viewers can still choose which houses within these areas
are most likely to fulfil their quotas, rather than being
Table 1 Characteristics of tobacco control surveys
Survey Sampling Frequency of data collection Tobacco control parameters measured
GHS/GLF Nationally representative
household surveys across
the UK.
N = ~ 14,500 adult smokers
and non-smokers.
Annual, smoking data collected since 1974.
From 2005, respondents followed-up for 4 years,
with ~25% replaced each year.
Smoking prevalence; cigarette consumption;
cigarette type; cigarette dependence; tar yield; age
started smoking; desire to quit; demographics.
HSE Nationally representative
household surveys across
England.
N = 5000-15000 adults smokers
and non-smokers.
Annual, since 1991.
No follow-up.
Smoking prevalence; cigarette consumption;
cigarette type; cigarette dependence; salivary
cotinine (biochemical indicator of cigarette smoke
intake); focus in 2007 on Smokefree legislation.
ONS Nationally representative
household surveys across
the UK.
N = ~1,800 adult smokers and
non-smokers.
Monthly, since 1990. Basic smoking questions
asked routinely in 2 months each year. Additional
smoking questions included when requested.
Varies month-to-month and year-to-year. At least
yearly: smoking prevalence, dependence, behaviour,
and habits. Previously requested: attitudes towards
smoking, quitting, and smoking restrictions;
awareness of health-risks; attempts to quit;
demographics.
ITC Random telephone dialling
across 20 countries (including
UK and USA); telephone
surveys.
N = ~2,000 adult smokers per
country.
Annual, since 2002.
Yearly follow-up with replenishment for drop-outs
and those who stop smoking.
Smoking behaviours and dependence; quitting
behaviours; use of alternative nicotine products;
attitudes towards and effects of label warnings,
advertising, and taxation; health beliefs;
demographics; other potential moderators.
ATTEMPT Internet recruitment and
assessment across the UK, USA,
France, and Canada.
N = ~2,000 adult smokers
intending to quit in next 3
months.
Survey lasted 2.5 years.
Tri-monthly follow-up.
Smoking behaviours and dependence; number and
method of quit attempts; reasons for quitting; short-
term health effects; weight-related measures;
demographics.
GHS/GLF, General Lifestyle Survey (formerly General Household Survey); HSE, Health Survey for England; ONS, Office of National Statistics Opinions Survey
(formerly Omnibus Survey); ITC, International Tobacco Control Policy Evaluation Project.
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sent to specific households in advance. Response rates
are not therefore appropriate to record, unlike random
probability sampling, where interviewers have no choice
as to the properties sampled and so response at each
address can be recorded. The analysis uses the rim
(marginal) weighting technique, an iterative sequence of
weighting adjustments whereby separate nationally
representative target profiles are set (for gender, working
status, prevalence of children in the household, age,
social grade and region) and the process repeated until
all variables match the specified targets.
Smokers and recent ex-smokers are asked at baseline
whether they are willing to be re-contacted. They are
mailed a short follow-up questionnaire three months
later, followed by a second at 6 months if they respond
to the first. Half of the respondents at three months are
randomly selected (after stratification by age and social
grade) to be sent a postal saliva sample kit to complete
and return with the questionnaire. The saliva is assayed
for cotinine, the primary metabolite of nicotine, enabling
biochemical assessment of smoking during the preced-
ing few days [18]. Follow-up participants are given up to
£5 remuneration (amounts varied slightly across the
four years of the study) and one reminder letter is sent.
The study was conceived by researchers at the Cancer
Research UK’s Health Behaviour Research Centre, Uni-
versity College London, who continue to manage it.
Ethical approval was granted by the University College
London ethics committee.
Samples
Between November 2006 and December 2010 a total of
90,568 participants completed the baseline survey
(monthly range = 1,634-2,642). Of these 23,326 reported
smoking within the last year. Response rates are not
available for the baseline survey due to the sampling
strategy used. Response rates are collected for the fol-
low-ups. Of the total 15,536 eligible for follow-up at
times when the 3-month questionnaire was scheduled,
14,025 were willing to be re-contacted (90%). Of these
4,755 (34%) returned a completed postal questionnaire.
Of the 7,013 asked to provide a saliva sample 1,702
(24%) returned a questionnaire at three months. Sixty
nine percent (n = 3,302) of those responding at three
months also returned a six month questionnaire.
Measures
A core set of key performance indicators are included in
each STS survey (see Table 2 for assessments routinely
included each month). Specific questions are added to
the survey to address particular issues (e.g. to assess the
impact of Smokefree legislation and public support for a
levy on tobacco products to fund tobacco control initia-
tives). The postal follow-up questionnaire is much
shorter. Questions include current smoking status, num-
ber of cigarettes smoked, attempts to stop and charac-
teristics of those attempts, attitudes towards smoking,
cutting down smoking behaviour and tobacco
dependence.
Smoking status and cigarettes smoked per day are
analysed in the current paper. Smoking status was
assessed with the following question: ‘Which of the fol-
lowing best applies to you? I smoke cigarettes (including
hand-rolled) every day, I smoke cigarettes (including
hand-rolled), but not every day; I do not smoke cigar-
ettes at all, but I do smoke tobacco of some kind (e.g.
pipe or cigar); I have stopped smoking completely in the
last year; I stopped smoking completely more than a
year ago; I have never been a smoker (i.e. smoked for a
year or more); Don’t Know’. Those who responded that
they smoked cigarettes every day or that they smoked
cigarettes but not every day are coded as current cigar-
ette smokers. Cigarette consumption is measured using
the following question ‘How many cigarettes per day
do/did you usually smoke’. Those who do not smoke
every day can give a figure per week or per month.
Socio-demographic information includes: gender, age,
and social grade based on information about the occu-
pation of the chief income earner, as used in the British
National Readership Survey [19]. The social grade
Table 2 Key assessments of the Smoking Toolkit Study
Smoking status Daily; non-daily; quit within the last year; quit more than a year ago; never smoked for a year or more; use of non-
cigarette tobacco
Amount smoked and
nicotine intake
Cigarettes or other tobacco products used per day, week, or month; salivary cotinine (follow-up only)
Nicotine dependence Fagerstrom Test for Nicotine Dependence, strength of urge to smoke
Route to quit Motivation to quit; triggers of quit attempts; barriers to quitting; attempts to quit; methods of quitting (including
pharmacological and behavioural aids, planning in advance, pre-quit cutting down); success at quitting
Motivation to smoke Attitudes, beliefs, and motives associated with smoking
Harm reduction Prevalence of attempts to cut down but not quit; use of nicotine replacement therapy when cutting down and/or
prohibited from smoking
Demographics Gender; age, socio-economic status; geographic region
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categories are: AB = higher and intermediate profes-
sional/managerial, C1 = supervisory, clerical, junior
managerial/administrative/professional, C2 = skilled
manual workers, D = semi-skilled and unskilled manual
workers, and E = on state benefit, unemployed, lowest
grade workers. These are dichotomised into ABC1 and
C2DE in the current analyses.
Statistical Analysis
We examined the heterogeneity of demographic charac-
teristics, smoking prevalence and cigarette consumption
estimates between the STS, GLF (English data only) and
HSE using the meta-analysis program Comprehensive
Meta-Analysis (CMA)[20] and the chi-square Q-test.
Where there was evidence of differences, we used pair-
wise chi-square or t-tests to examine these. No correc-
tion is made for multiple pair-wise comparisons.
HSE and GLF use the question ‘Do you smoke cigar-
ettes at all nowadays?’ (Yes/No) to assess smoking sta-
tus. From this question, national rates of cigarette
smoking prevalence are estimated, overall and by gen-
der, age and socioeconomic status. The mean number
of cigarettes smoked per day was assessed in both the
HSE and GLF surveys with the question ‘About how
many cigarettes a day do you usually smoke at week-
ends/on weekdays’. All data were weighted. Data from
HSE and GLF were adjusted for clustering using com-
plex samples procedures.
Although the STS has results for 2007-2010, full data
are only available from the GLF and HSE to 2008. The
2009 HSE and GLF prevalence results are available in
report format only [21,22]. For this analysis, 2009 per-
centages were taken from these published reports and
the standard errors (confidence intervals) have been esti-
mated from sample sizes and standard errors published
for previous years.
Full details of the methodology for HSE and GLF are
available in published reports [23-26] and online [27,28].
However, in brief, both surveys provide a sample repre-
sentative of the population living in private households,
using a multi-stage stratified probability design. Specific
addresses are selected from chosen postcode sectors and
letters sent to these households prior to an interviewer
visit. All members of the household are then interviewed
on a range of topics by trained interviewers using com-
puter assisted interviewing.
Results
Table 3 shows the demographic characteristics of base-
line STS respondents in 2007 and 2008, when GLF and
HSE data were also available. As might be expected with
weighted data, there was no evidence of heterogeneity in
the demographic characteristics of the three surveys in
2007, except for Socio-Economic Status (SES). Pair-wise
comparisons showed that the GLF SES profile was
significantly different from that of the STS (X2 = 47.7,
p < 0.001) and the HSE (X2 = 7.9, p = 0.005). In 2008
all three surveys differed slightly in terms of SES, and
there was also a lower proportion of men in GLF com-
pared with both STS (X2 = 6.7, p = 0.010) and HSE (X2
= 11.3, p = 0.001).
Figure 1 shows the pattern of smoking prevalence and
cigarette consumption across years for each study,
including STS data up to 2010. The overall prevalence
estimates differed between all three surveys in 2007, but
not in other years (Table 4). STS prevalence was higher
than for the HSE (X2 = 6.1, p = 0.014) and the GLF (X2
= 22.1, p < 0.001), and GLF prevalence was lower than
the STS (above) and HSE (X2 = 5.3, p = 0.02). Differ-
ences were apparent for both genders. In 2007 there
was also evidence of prevalence differences between the
surveys for all age groups except those aged 65 plus.
There was no consistent pattern to these differences. In
2008 there was only evidence of a difference between
the surveys for 25-44 year olds, with the GLF giving a
lower estimate than both STS (X2 = 4.1, p = 0.043) and
Table 3 Demographic characteristics of the STS, HSE and
GLF (percent, 95% confidence interval unless stated)
2007 2008
Male (%, 95% C.I.)
STS 48.5 (47.9 to 49.2) 48.5 (47.8 to 49.3)
GLF 48.6 (47.7 to 49.5) 47.1(46.4 to 47.8)
HSE 48.8 (47.9 to 49.7) 48.8 (48.2 to 49.5)
Heterogeneity X2 = 0.27, p = 0.875 X2 = 12.7, p = 0.002
Age (mean, 95% C.I.)
STS 46.4 (46.1 to 46.7) 46.3 (46.0 to 46.6)
GLF 46.4 (46.1 to 46.7) 47.3 (46.7 to 47.9)
HSE 46.4 (45.8 to 47.0) 46.3 (45.8 to 46.8)
Heterogeneity X2 = 0.00, p = 1.00 X2 = 5.8, p = 0.056
Lower social grade
(%, 95% C.I.)*
STS 44.6 (43.9 to 45.2) 44.5 (43.8 to 45.3)
GLF 40.3 (39.4 to 41.3) 39.4 (38.0 to 40.8)
HSE 43.0 (41.4 to 44.6) 42.8 (41.7 to 43.9)
Heterogeneity X2 = 47.7, p < 0.001 X2 = 38.9, p < 0.001
*STS = social grade, HSE = NSSEC (household) split Professional/Managerial/
Intermediate & Routine/Manual
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Figure 1 Smoking prevalence and cigarettes per day by survey
and year.
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HSE (X2 = 7.9, p = 0.005). For both 2007 and 2008
there were differences between the three surveys in pre-
valence estimates by socioeconomic status. Prevalence
was higher in STS compared with GLF in 2007 in both
higher SES (X2 = 12.5, p < 0.001) and lower SES (X2 =
25.6, p < 0.001) groups. In 2008 there was no difference
between STS and GLF, but the STS estimate was lower
than the HSE estimate in the higher SES group (X2 =
11.4, p = 0.001) and higher than the HSE estimate in
the lower SES group (X2 = 7.1, p = 0.008).
In 2009 the question to assess prevalence used in GLF
and HSE was piloted in the STS. It gave an estimate of
21.5%, the same as from the standard STS question, and
similar to the published GLF (21%) and HSE (22%) figures.
Table 4 Cigarette smoking prevalence (percent, 95% CI) by sociodemographics for each survey from 2007-2009 where
available
2007 2008 2009†
Total STS 24.1 (23.6 to 24.7) 22.0 (21.4 to 22.6) 21.5 (21.0 to 22.1)
population GLF 20.5 (19.8 to 21.3) 20.9 (19.9 to 22.0) 21 (20.0 to 22.0)
HSE 22.3 (21.0 to 23.6) 21.7 (20.9 to 22.6) 22 (20.4 to 23.6)
Heterogeneity X2 = 50.3, p < 0.001 X2 = 2.97, p = 0.227 X2 = 1.3, p = 0.535
Gender
Men STS 25.6 (24.7 to 26.4) 22.9 (22.0 to 23.8) 22.6 (21.8 to 23.5)
GLF 22.0 (20.8 to 23.2) 21.9 (20.6 to 23.3) 22 (20.7 to 23.3)
HSE 23.8 (22.1 to 25.5) 23.7 (22.5 to 25.0) 24 (21.8 to 26.2)
Heterogeneity X2 = 22.4, p < 0.001 X2 = 3.7, p = 0.159 X2 = 2.4, p = 0.306
Women STS 22.8 (22.0 to 23.6) 21.2 (20.4 to 22.0) 20.5 (19.7 to 21.3)
GLF 19.2 (18.2 to 20.3) 20.1 (18.9 to 21.3) 20 (18.8 to 21.2)
HSE 20.8 (19.4 to 22.4) 19.9 (18.9 to 20.8) 20 (18.1 to 21.9)
Heterogeneity X2 = 29.2, p < 0.001 X2 = 4.7, p = 0.095 X2 = 0.58, p = 0.750
Age
16-24 STS 32.7 (31.2 to 34.3) 29.3 (27.7 to 31.0) 28.3 (26.8 to 29.9)
GLF 27.2 (24.3 to 30.0) 27.6 (24.4 to 31.1) -
HSE 25.3 (21.8 to 29.2) 26.2 (23.9 to 28.6) -
Heterogeneity X2 = 20.2, < 0.001 X2 = 4.6, p = 0.099 -
25-44 STS 28.2 (27.2 to 29.2) 27.1 (26.0 to 28.1) 26.3 (25.3 to 27.3)
GLF 24.4 (23.0 to 25.8) 24.9 (23.1 to 26.8) -
HSE 27.9 (25.7 to 30.0) 28.4 (26.8 to 30.0) -
Heterogeneity X2 = 19.5, p < 0.001 X2 = 7.9, p = 0.019 -
45-64 STS 23.3 (22.3 to 24.3) 20.3 (19.3 to 21.3) 20.5 (19.5 to 21.5)
GLF 20.8 (19.5 to 22.2) 20.8 (19.3 to 22.5) -
HSE 21.3 (19.5 to 23.3) 19.2 (18.0 to 20.5) -
Heterogeneity X2 = 0.95, p = 0.008 X2 = 2.76, p = 0.251 -
65+ STS 11.1 (10.2 to 12.1) 9.7 (8.7 to 10.6) 9.4 (8.5 to 10.3)
GLF 9.5 (8.5 to 10.7) 10.1 (9.0 to 11.4) -
HSE 11.2 (9.6 to 13.0) 10.2 (9.2 to 11.3) -
Heterogeneity X2 = 4.6, p = 0.100 X2 = 0.49, p = 0.784 -
SES*
High SES STS 17.9 (17.3 to 18.6) 15.3 (14.6 to 16.0) 15.7 (15.1 to 16.4)
GLF 15.7 (14.8 to 16.7) 16.0 (14.9 to 17.2) -
HSE 16.9 (15.5 to 18.4) 17.4 (16.5 to 18.4) -
Heterogeneity X2 = 12.6, p = 0.002 X2 = 11.4, p = 0.0003 -
Low SES STS 31.9 (31.0 to 32.8) 30.4 (29.4 to 31.4) 29.1 (28.1 to 30.0)
GLF 27.5 (26.1 to 29.0) 29.3 (27.6 to 31.0) -
HSE 29.8 (27.8 to 31.9) 28.0 (26.6 to 29.5) -
Heterogeneity X2 = 26.2, p < 0.001 X2 = 7.3, p = 0.027 -
†Data in 2009 is only available for GLF and HSE in published reports and is not appropriately split by age and socio-economic status. Confidence intervals for
GLF and HSE in 2009 are estimated based on actual base sample size and confidence intervals in previous years.
*STS = social grade split ABC1 (high SES) & C2DE (low SES), HSE = NSSEC (household) split Professional/Managerial/Intermediate (high SES) & Routine/Manual
(low SES).
Fidler et al. BMC Public Health 2011, 11:479
http://www.biomedcentral.com/1471-2458/11/479
Page 5 of 9
There were no differences in the estimates of cigarette
consumption between the surveys (Table 5) except
among men and 16-24 year olds in 2008, where STS
consumption was higher than GLF (X2 = 4.7, p = 0.030)
and higher than both GLF (X2 = 3.9, p = 0.042) and
HSE (X2 = 6.44, p = 0.048), respectively.
No comparison is made between STS follow-up data
and other surveys. However, compared with baseline STS
smokers and recent ex-smokers who did not provide fol-
low-up data, those responding at three months were
significantly older (difference = 4.3 years, t = -15.13,
p < 0.001) and were more likely to be female (difference
= 7.8%, X2 = 82.1, p < 0.001). There was no difference by
social grade (X2 = 1.2, p = 0.281). Those baseline smo-
kers and ex-smokers who provided follow-up data at six
months were also significantly older (t = -21.16, p <
0.001) and more likely to be female (X2 = 55.1, p <
0.001) than those who were not successfully followed-up.
Again there was no difference by social grade (X2 = 0.04,
p = 0.833).
Table 5 Mean (standard error) cigarettes per day by sociodemogrpahics for each survey from 2007-2009 where
available
2007 2008 2009†
Total STS 13.4 (0.12) 13.4 (0.13) 13.1 (0.12)
population GLF 13.1 (0.19) 13.1 (0.23) -
HSE 13.2 (0.27) 13.0 (0.17) -
Heterogeneity X2 = 1.9, p = 0.379 X2 = 3.9, p = 0.145
Men STS 14.1 (0.17) 14.3 (0.20) 13.8 (0.19)
GLF 13.9 (0.30) 13.5 (0.31) -
HSE 14.0 (0.41) 13.7 (0.24) 13.6 (0.52)
Heterogeneity X2 = 0.35, p = 0.839 X2 = 6.2, p = 0.044 X2 = 0.13, p = 0.718
Women STS 12.6 (0.15) 12.6 (0.18) 12.4 (0.16)
GLF 12.3 (0.23) 12.7 (0.28) -
HSE 12.4 (0.30) 12.2 (0.18) 12.6 (0.41)
Heterogeneity X2 = 1.3, p = 0.520 X2 = 3.4, p = 0.181 X2 = 0.21, p = 0.650
16-24 STS 11.0 (0.20) 12.0 (0.27) 10.8 (0.21)
GLF 10.6 (0.38) 10.7 (0.60) -
HSE 11.4 (0.73) 11.1 (0.35) -
Heterogeneity X2 = 1.3, p = 0.525 X2 = 6.4, p = 0.040
25-44 STS 13.0 (0.18) 13.0 (0.20) 12.4 (0.18)
GLF 12.6 (0.31) 12.5 (0.34)
HSE 12.5 (0.39) 12.4 (0.24)
Heterogeneity X2 = 2.1, p = 0.342 X2 = 4.2, p = 0.125
45-64 STS 15.6 (0.24) 15.5 (0.27) 15.6 (0.25)
GLF 14.9 (0.31) 15.1 (0.35)
HSE 15.1 (0.44) 15.2 (0.29)
Heterogeneity X2 = 3.4, p = 0.180 X2 = 0.99, p = 0.608
65+ STS 13.5 (0.38) 12.9 (0.44) 13.5 (0.45)
GLF 13.1 (0.58) 12.7 (0.54) -
HSE 13.5 (0.65) 13.2 (0.49) -
Heterogeneity X2 = 0.36, p = 0.835 X2 = 0.49, p = 0.784
High SES* STS 12.2 (0.17) 12.2 (0.21) 12.1 (0.18)
GLF 12.2 (0.27) 12.5 (0.33) -
HSE 12.6 (0.39) 11.7 (0.23) -
Heterogeneity X2 = 0.93, p = 0.629 X2 = 4.7, p = 0.097
Low SES STS 14.2 (0.15) 14.2 (0.17) 13.8 (0.16)
GLF 14.1 (0.27) 13.9 (0.29) -
HSE 13.8 (0.38) 14.0 (0.22) -
Heterogeneity X2 = 0.98, p = 0.612 X2 = 1.0, p = 0.602
*STS = social grade, HSE = NSSEC (household) split Professional/Managerial/Intermediate & Routine/Manual
†Data in 2009 for GLF and HSE is only available from published reports. Only HSE reported mean cigarette consumption, split by gender is available.
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Discussion
The Smoking Toolkit Study provides monthly nationally
representative data on key indicators of smoking beha-
viour, cessation, and tobacco control initiatives. The
STS methodology appears to be robust and reliable,
yielding similar results to well-established surveys from
the UK on common measures despite some methodolo-
gical differences.
Prevalence data in 2008 and 2009 were comparable
across all surveys. However, in 2007 all three surveys
produced significantly different prevalence rates. It is
unclear why this might be. A potential explanation
relates to the number of policy changes that occurred in
2007, including the banning of smoking in enclosed
public places and the change in age of sale of tobacco
from age 16 to 18. STS monthly prevalence fluctuated
substantially over 2007 [12]. However, STS does not
stand out as anomalous in comparison with the other
surveys. Prevalence by gender and age were broadly
similar across the surveys, although some differences are
notable in 2007, probably also reflecting the differences
in total population prevalence described above and so
again it is unclear as to why this might be. Differences
in prevalence by socioeconomic status were observed in
both 2007 and 2008. This is not surprising given the dif-
ferent measures used, but despite this a clear and similar
pattern in prevalence by SES is apparent in all three sur-
veys with smoking prevalence consistently higher among
those in lower SES groups. Levels of cigarette consump-
tion on the other hand were very similar across all sur-
veys and years.
Prevalence data from the GLS and HSE were unavail-
able for 2010 at the time of writing, highlighting the
current lack of up-to-date figures from these surveys. It
should also be reiterated that the 2009 data were taken
from published survey reports and smoking prevalence
for certain sub-groups was therefore not available. Con-
fidence intervals for GLF and HSE in 2009 were esti-
mated based on actual base sample size and confidence
intervals from previous years and may therefore be
slightly inaccurate. This further draws attention to the
lack of available recent data from these surveys. STS
results are available shortly after collection and data
accessible at request.
As with all studies, there are certain limitations that
apply to the STS specifically, and surveys in general.
The data presented here are all estimates of smoking
prevalence in the population. Although we have shown
that the three surveys provide fairly similar estimates,
they may all not fully reflect true smoking prevalence.
This could be due to inaccuracies in the responses of
participants,[29] or perhaps a tendency for smokers to
be less likely to agree to participate in such surveys in
the first place. Although such nationally representative
survey data are considered the ‘gold standard’ in obtain-
ing prevalence statistics, this caveat should be recog-
nised when citing prevalence estimates. More specific to
the STS, data on the methodology and response rates
for the follow-up surveys are presented, although it is
not appropriate to report prevalence figures as only
smokers and recent ex-smokers are surveyed. The
response rate for follow-up is low, as is the return of
useable saliva samples. However, data are available to
establish the representativeness of the follow-up samples
on key variables by comparison with those not followed
up. Other limitations of the STS include the lack of data
on ethnicity at baseline or follow-up. The impact of eth-
nicity on key parameters cannot therefore be estab-
lished, although the proportions in each individual
ethnic group would not yield a big enough sample to be
useful, even with the very large aggregate sample size.
Special studies are required to investigate smoking
patterns in these groups. Finally, the STS is restricted to
data from England, so cannot document the whole of
the UK.
The STS has several key strengths, including the
ability to examine changes in prevalence and other key
performance indicators, such as quit attempts and moti-
vation to quit, on a timely basis and track changes
monthly. This permits a more sensitive test of the possi-
ble effects of interventions than can be achieved by
annual surveys. It also collects sufficient information on
characteristics of quit attempts and other relevant vari-
ables to provide information on methods of quitting and
how these relate to success rates and contextual vari-
ables. The large sample size and frequent follow-up
allow for these relationships to be accurately estimated
and tested prospectively. Indeed, the STS has already
produced several important findings, some of which are
briefly summarised below.
In terms of policy changes, the STS was able to show
that there was a significant temporary increase in smo-
kers attempting to stop by about 300,000 following the
introduction of Smokefree legislation [12]. Equally,
there is evidence from the STS that the increase in the
legal age of sale from 16 to 18 was followed by a
decrease in smoking prevalence in this age group, sug-
gesting that these legislative changes can have a real
impact on smoking behaviour [9]. Data from the STS
also indicate that the general public is much less
averse to radical policy changes, such as raising the
price of cigarettes to fund tobacco control activities or
a total ban on the sale of tobacco products, than is
usually assumed [11,15].
Regarding the process of smoking cessation, STS data
indicate that enjoyment and stress relief are the most
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popular reasons given for continued smoking, with
men more likely to report enjoyment and women
stress relief [10]. While enjoyment of smoking is seen
by smokers as a major barrier to stopping,[8] ex-smo-
kers overwhelmingly report being happier than when
they were smoking [16]. This provides some reassur-
ance to would-be quitters that their quality of life is
likely to improve if they stop [16]. Data from the STS
also suggest that there are significant differences in
reported triggers for quit attempts as a function of
socio-demographic factors. Smokers with higher SES
are more likely to report concern about future health
whereas those from lower SES are more likely to cite
cost and current health problems [17]. However, lower
SES smokers are not less likely to try to stop smoking
but are less likely to succeed, indicating that structural
factors have an important role in aiding smoking ces-
sation [14]. Moreover, failed quit attempts lasting less
than a week are quickly forgotten,[6] underlining the
need for the frequent assessment of smoking key para-
meters, with cigarette dependence being the main
determinant of the success of quit attempts [8]. There
is also evidence that a simple rating of the strength of
urges to smoke during a normal smoking day may be a
better measure of cigarette dependence than those cur-
rently used [7]. Lastly, data from the STS have shed
light on the use of support for smoking cessation, find-
ing that half of all quit attempts are aided by some
form of pharmacological or behavioural treatment [13].
However, the use of the most effective treatment
option, the National Stop Smoking Services, is
relatively low[13] and pharmacological support is
increasingly employed to aid smoking reduction and
temporary abstinence [5].
Conclusions
In conclusion, the Smoking Toolkit Study provides reli-
able, up-to-date data on key smoking parameters in
England and has already yielded valuable insights into
smoking patterns at a national level. Key findings are
published on a dedicated website: http://www.smokingi-
nengland.info. Data from the STS have the potential to
continue to enhance our understanding of smoking
behaviours and provide important contributions to
future tobacco control policy and the development of
new smoking cessation interventions.
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